Discontinuation report REOPRO
| Report ID | 52434 |
| Drug Identification Number | 02216973 |
| Brand name | REOPRO |
| Common or Proper name | abciximab solution for intravenous injection |
| Company Name | JANSSEN INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ABCIXIMAB |
| Strength(s) | 2MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 1x5ml |
| ATC code | B01AC |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2018-06-14 |
| Actual discontinuation date | 2018-06-14 |
| Remaining supply date | 2018-04-05 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | no supply avaible |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 19 GREEN BELT DRIVE TORONTO, ONTARIO CANADA M3C 1L9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2018-06-15 | English | Compare |
| v2 | 2018-06-14 | French | Compare |
| v1 | 2018-06-14 | English | Compare |
Showing 1 to 3 of 3